forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Receptor Agonist Market Size & Trends 2035 GLP-1 trends 2025: real-world data,

Vulnerable populations such as frail patients, pregnant women, adolescents and the elderly may be more susceptible to adverse effects like muscle loss or nutritional deficits

As childhood obesity and youth-onset type 2 diabetes mellitus (T2DM) continue to rise worldwide, a new systematic review highlights glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as promising options that extend beyond lifestyle modification and metformin

And physically, stress hormones can blunt the bodys physical response to sexual cues

This post explains the most common reasons people feel tired on semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medicines, plus simple food-first fixes that usually help

Frequently Asked Questions What are the most common side effects of GLP-1 medications